IPP Bureau

Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India
Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India

By IPP Bureau - November 21, 2025

The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas

SOMA and Aura partner to advance innovation in on-press color correction
SOMA and Aura partner to advance innovation in on-press color correction

By IPP Bureau - November 21, 2025

SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press

Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification
Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification

By IPP Bureau - November 21, 2025

Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub

Innovent Biologics’ experimental weight-loss drug achieves breakthrough in Phase 3 trial
Innovent Biologics’ experimental weight-loss drug achieves breakthrough in Phase 3 trial

By IPP Bureau - November 21, 2025

Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration

Siolta Therapeutics’ novel microbiome therapy shows promise in preventing allergic diseases in infants
Siolta Therapeutics’ novel microbiome therapy shows promise in preventing allergic diseases in infants

By IPP Bureau - November 21, 2025

EMA launches streamlined process to fast-track critical medicines, vaccines
EMA launches streamlined process to fast-track critical medicines, vaccines

By IPP Bureau - November 21, 2025

The move is expected to be crucial during health crises

in-cosmetics Asia 2025 smashes records, draws global beauty elite
in-cosmetics Asia 2025 smashes records, draws global beauty elite

By IPP Bureau - November 21, 2025

Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation

Thyrocare launches comprehensive GLP-1 health check across India
Thyrocare launches comprehensive GLP-1 health check across India

By IPP Bureau - November 21, 2025

Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion

FDA nod to Koselugo for adults with Rare NF1 tumors, expanding life-changing treatment
FDA nod to Koselugo for adults with Rare NF1 tumors, expanding life-changing treatment

By IPP Bureau - November 21, 2025

Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare

By IPP Bureau - November 21, 2025

The initiative aims to connect startups and tech companies with its business units,

Lilly expands biotech footprint with new Gateway Labs in Philadelphia
Lilly expands biotech footprint with new Gateway Labs in Philadelphia

By IPP Bureau - November 21, 2025

The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies

Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses

By IPP Bureau - November 19, 2025

The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore

Cardiol Therapeutics wins US patent protection for heart-disease drug platform
Cardiol Therapeutics wins US patent protection for heart-disease drug platform

By IPP Bureau - November 19, 2025

The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38

Meduloc wins FDA green light for new class of bone-fracture fixation system
Meduloc wins FDA green light for new class of bone-fracture fixation system

By IPP Bureau - November 19, 2025

The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability

Chiesi inks agreement with AbbVie subsidiary to push next-generation brain-targeting therapies for rare diseases
Chiesi inks agreement with AbbVie subsidiary to push next-generation brain-targeting therapies for rare diseases

By IPP Bureau - November 19, 2025

Latest Stories

Interviews

Packaging